Yat Sun Or, Ph.D.

Yat Sun Or, Ph.D.

Chief Scientific OfficeratEnanta Pharmaceuticals· In proxies 2021–2025

Pay in FY2022+24% from the year before · Enanta Pharmaceuticals stock -8.7% the same year

Yat Sun Or, Ph.D. was paid $2.5M in FY2022 (Sep), up 24%. Enanta Pharmaceuticals stock fell 8.7% that year.

Pay$100 in the stock at the end of FY20 → $113
Pay is from the Summary Compensation Table of each Enanta Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Enanta PharmaceuticalsPublic company · 5 yr
    • Chief Scientific Officer2021 – Present · 5 yrStock in role -73%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?